All
Anti-PD-L1 Antibody Drug Combo May Improve Outcomes in Advanced Kidney Cancer
Benmelstobart plus anlotinib significantly improved survival versus Sutent in the first-line treatment of advanced renal cell carcinoma.
Celebrating 4 Years Cancer-Free
I invited my family to gather with me and celebrate four years of being cancer-free.
NBA Star Dikembe Mutombo Dies of Brain Cancer
The Hall of Famer has died from brain cancer at the age of 58, the NBA has announced.
Chemo Shortage Increases Treatment Costs by 16% for Head and Neck Cancer
In addition to increased treatment costs, patients with head and neck cancers also experienced therapy changes during the cisplatin shortage.
Lower Keytruda Doses May Be as Effective as Standard Doses for Stage 4 NSCLC
Patients with stage 4 non-small cell lung cancer may derive an equal benefit with a lower dose of Keytruda versus the standard dose.
Side Effects, Quality of Life Important to Consider in Breast Cancer Subset
Patients with HER2-positive metastatic breast cancer may consider related side effects and quality of life outcomes when choosing treatments.
Guiding Hope for Patients With Lung Cancer
Two colleagues of Amy Wallace, an oncology nurse, nominated her for the Extraordinary Healer Award based on her care of patients with lung cancer.
Path to Previvor: My Journey from Diagnosis to Advocacy
My path as a previvor is far from being straightforward, but having available resources and support has helped me along the way.
FDA Approves Retevmo for Some With Medullary Thyroid Cancer
The approval of Retevmo is for the treatment of adults and children aged 2 years and older with advanced or metastatic medullary thyroid cancer.
Prostate Cancer Questions Answered on Surgery, Side Effects and More
An expert answered CURE® readers’ questions on several aspects of a prostate cancer journey, including treatment options and sexual function.
There is Nothing Pink About Breast Cancer
As a caregiver to my daughter who had breast cancer, pink takes on a new meaning for us — one I’m not quite a fan of.
Ann Wilson of Heart Returns After Chemo, Ryan Reynolds Visits Young Patient and More
From Ann Wilson’s return to Heart after chemotherapy to Ryan Reynolds visiting a fan with cancer, here’s what’s happening in the oncology space this week.
Supplemental New Drug Application Submitted for Nubeqa in Prostate Cancer Subset
The FDA received an application for Nubeqa as a potential treatment option with androgen deprivation therapy for metastatic hormone-sensitive prostate cancer.
Cediranib Added to Lynparza Didn’t Improve Progression, Survival in Ovarian Cancer
A Lynparza/cediranib combo had similar results versus standalone Lynparza among patients with relapsed platinum-sensitive ovarian cancer.
Palliative Care in Kidney Cancer More Than Just Relieving Symptoms
Patients with kidney cancer who want more support during treatment can consider palliative care, whether it’s for symptoms or discussing goals and values.
3 Ways You Can Participate in Mesothelioma Awareness Day
As a cancer survivor, I’ve found three impactful ways to get involved in Mesothelioma Awareness Day to help make a difference.
Kidney Cancer Questions Answered, From Protein Intake to Clinical Trials
An expert provides answers to readers’ questions regarding different aspects of the kidney cancer experience, such as protein intake and clinical trials.
Imjudo Plus Imfinzi Improve Survival Versus Nexavar in Liver Cancer
In patients with unresectable liver cancer, treatment with Imjudo plus Imfinzi showed better survival outcomes compared with Nexavar.
FDA Approves Tagrisso for Some With Advanced NSCLC
Tagrisso has been approved for some adults with locally advanced, unresectable stage 3 non-small cell lung cancer.
10 Commonly Asked Lung Cancer Questions With Dr. Jyoti Malhotra
Following a CURE® Educated Patient® Lung Cancer Summit, the City of Hope expert answered 10 commonly asked questions from patients with lung cancer.
Bringing Awareness to Depression and Cancer
Before receiving my colorectal cancer diagnosis, I had experienced cancer. However, my depression felt different during treatment.
Study Suggests Using Caution With ChatGPT for Breast Cancer Information
When given commonly asked questions regarding breast cancer, ChatGPT’s answers were incorrect a quarter of the time and often provided fake references.
Survival Benefit Continues at 10 Years From Opdivo Either Alone or With Yervoy in Advanced Melanoma
Findings from the CheckMate 067 of patients with advanced melanoma include the longest follow-up of a checkpoint inhibitor in any tumor type.
Krazati Associated With Superior Outcomes Than Docetaxel in KRAS G12C+ NSCLC
Krazati’s benefits were seen regardless of baseline brain metastases, researchers have reported in findings from the KRYSTAL-12 trial.
Kidney Cancer FAQs Answered on Treatments, Care Teams and More
An expert provides answers to pressing questions regarding different aspects of a kidney cancer journey, including stage, grade and treatment options.
Navigating the Cancer Journey With Two Different Approaches
Two vastly different approaches to navigating the cancer journey may or may not be mutually exclusive.
Reblozyl May Be ‘The Standard of Care’ Now in Lower-Risk MDS, Anemia
An expert discussed the findings of the COMMANDS trial evaluating Reblozyl’s role in red blood cell transfusion independence for patients with MDS.
Imfinzi Improves Survival Outcomes in Subgroups of Patients with LS-SCLC
Among patients with limited-stage small cell lung cancer, the benefits of consolidation Imfinzi were seen across a number of subgroups.
Nubeqa Plus ADT Outperformed ADT Alone in Treating Prostate Cancer
Adding Nubeqa to androgen deprivation therapy improved radiographic progression-free survival in patients with metastatic hormone-sensitive prostate cancer.
Outpatient CAR-T Cell Therapy May Be Safe in Hematologic Malignancies
CAR-T cell therapies administered in an outpatient setting may be safe and feasible without intensive remote monitoring in hematologic malignancies.